EML4 and squamous cell carcinoma: Fifty-nine EML4-ALK-positive cases were identified, and the positive rate was 4.88% (59/1208); the positive rate was 5.84% (58/994) in adenocarcinoma and 0.47% (1/214) in squamous cell carcinoma.